These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 12527890

  • 1. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J, Ma C, Huang Y, Luo J, Huang C.
    Oncogene; 2003 Jan 16; 22(2):211-9. PubMed ID: 12527890
    [Abstract] [Full Text] [Related]

  • 2. The role of epidermal growth factor receptor in ethanol-mediated inhibition of activator protein-1 transactivation.
    Ma C, Bower KA, Lin H, Chen G, Huang C, Shi X, Luo J.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1785-94. PubMed ID: 15878157
    [Abstract] [Full Text] [Related]

  • 3. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 15; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 4. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2000 Jun 15; 183(3):338-46. PubMed ID: 10797308
    [Abstract] [Full Text] [Related]

  • 5. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
    Gallardo G, Tabraue C, Quintana J, López-Blanco F, Cabrera J, Díaz R, Estévez F, Ruiz de Galarreta CM, Fanjul LF, Santana P.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 15; 46(7):1305-12. PubMed ID: 11075960
    [Abstract] [Full Text] [Related]

  • 6. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T, Ma J, Cao X.
    Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832
    [Abstract] [Full Text] [Related]

  • 7. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.
    Dong Z, Huang C, Ma WY.
    Anticancer Res; 1999 Dec 01; 19(5A):3743-7. PubMed ID: 10625951
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F, Hui YN, Li YJ, Guo CM, Meng H.
    Ophthalmologica; 2007 Dec 01; 221(4):244-50. PubMed ID: 17579290
    [Abstract] [Full Text] [Related]

  • 9. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH.
    Oncogene; 1998 Dec 31; 17(26):3493-8. PubMed ID: 10030673
    [Abstract] [Full Text] [Related]

  • 10. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 31; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 11. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
    Zhong S, Quealy JA, Bode AM, Nomura M, Kaji A, Ma WY, Dong Z.
    Cancer Res; 2001 May 15; 61(10):4084-91. PubMed ID: 11358830
    [Abstract] [Full Text] [Related]

  • 12. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
    Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z.
    Cancer Res; 2001 Aug 01; 61(15):5749-56. PubMed ID: 11479211
    [Abstract] [Full Text] [Related]

  • 13. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L, Watanabe M, Chikamori M, Kido Y, Yamamoto T, Shibuya M, Gotoh N, Tsuchida N.
    Oncogene; 2006 Oct 19; 25(49):6457-66. PubMed ID: 16702953
    [Abstract] [Full Text] [Related]

  • 14. EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells.
    Lei W, Mayotte JE, Levitt ML.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):939-45. PubMed ID: 9588219
    [Abstract] [Full Text] [Related]

  • 15. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W, Rosenberg MP, DiGiovanni J.
    Oncogene; 1997 Mar 27; 14(12):1435-44. PubMed ID: 9136987
    [Abstract] [Full Text] [Related]

  • 16. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
    Starbuck C, Lauffenburger DA.
    Biotechnol Prog; 1992 Mar 27; 8(2):132-43. PubMed ID: 1368006
    [Abstract] [Full Text] [Related]

  • 17. Na+/K+/Cl- cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK.
    Panet R, Eliash M, Atlan H.
    J Cell Physiol; 2006 Mar 27; 206(3):578-85. PubMed ID: 16222701
    [Abstract] [Full Text] [Related]

  • 18. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Mar 27; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 19. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 20. Correlation between EGFR Y1068 tyrosine phosphorylation and AP-1 activation by tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin.
    Cichocki M, Szamałek M, Dałek M, Baer-Dubowska W.
    Environ Toxicol Pharmacol; 2012 Jan 07; 33(1):92-7. PubMed ID: 22196048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.